Anfield Capital Management, LLC Merck & Co., Inc. Transaction History
Anfield Capital Management, LLC
- $263 Million
- Q4 2024
A detailed history of Anfield Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Anfield Capital Management, LLC holds 286 shares of MRK stock, worth $22,308. This represents 0.01% of its overall portfolio holdings.
Number of Shares
286
Previous 301
4.98%
Holding current value
$22,308
Previous $34,000
17.65%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MRK
# of Institutions
3,950Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$19.6 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.43 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$4.77 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.45 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $198B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...